# Yallaferon in Chinese Population

> **NCT02593968** · PHASE2 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 100 (estimated)

## Conditions studied

- HPV Infection

## Interventions

- **DRUG:** Recombinant Human Interferon a-2b Gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02593968
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593968, "Yallaferon in Chinese Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02593968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*